For the quarter ending 2025-09-30, ARTV has $148,862K in assets. $19,638K in debts. $25,508K in cash and cash equivalents.
| Balance Sheets | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Cash and cash equivalents | 25,508 | 28,468 | ||
| Short-term investments | 97,460 | 113,897 | ||
| Other receivables (including related party amounts of 37 and 0, respectively) | 79 | 30 | ||
| Prepaid expenses and other current assets | 6,477 | 6,671 | ||
| Total current assets | 129,524 | 149,066 | ||
| Restricted cash | 461 | 461 | ||
| Property and equipment | 14,789 | - | ||
| Less accumulated depreciation | 7,808 | - | ||
| Property and equipment, net | 6,981 | 6,886 | ||
| Operating lease right-of-use assets | 11,262 | 12,709 | ||
| Financing lease right-of-use asset | 216 | 231 | ||
| Other long-term assets | 418 | 38 | ||
| Total assets | 148,862 | 169,391 | ||
| Accounts payable (including related party amounts of 0 and 276, respectively) | 848 | 1,215 | ||
| Accrued expenses (including related party amounts of 12 and 713, respectively) | 7,026 | 5,838 | ||
| Current portion of operating lease liabilities | 3,097 | 3,536 | ||
| Current portion of financing lease liability | 75 | 106 | ||
| Other current liabilities | 73 | 73 | ||
| Total current liabilities | 11,119 | 10,768 | ||
| Operating lease liabilities, net of current portion | 8,519 | 9,582 | ||
| Total liabilities | 19,638 | 20,350 | ||
| Common stock, 0.0001 par value 700,000,000 shares authorized at september 30, 2025 and december 31, 2024 24,544,904 and 24,291,607 shares issued and outstanding at september 30, 2025 and december 31, 2024 respectively | 3 | 3 | ||
| Additional paid-in capital | 438,911 | 437,285 | ||
| Accumulated other comprehensive income (loss) | 87 | 2 | ||
| Accumulated deficit | -309,777 | -288,249 | ||
| Total stockholders' equity | 129,224 | 149,041 | ||
| Total liabilities and stockholders' equity | 148,862 | 169,391 | ||
Artiva Biotherapeutics, Inc. (ARTV)
Artiva Biotherapeutics, Inc. (ARTV)